Cryoport and VGCI partner to advance cell and gene therapy supply chain
Temperature-controlled supply chain solutions firm Cryoport has partnered with VGCI, a subsidiary of GeneOne Life Science, to support the development of cell and gene therapies and mRNA-based treatments.